Allan Mandelzys
President bei 8569975 Canada, Inc.
Profil
Allan Mandelzys is currently the Chairman at Searchlight Pharma, Inc. and holds positions as a Director at Matrizyme Pharma Corp.
and President & Director at 8569975 Canada, Inc. He previously served as the Chief Executive Officer & Director at Thallion Pharmaceuticals, Inc. from 2010 to 2013.
He also held positions as a Director at Kane Biotech, Inc. and Allelix Biopharmaceuticals, Inc. and as Vice President-Business Development at Labopharm, Inc. from 2000 to 2006.
Additionally, he served as an Independent Director at Clementia Pharmaceuticals, Inc. from 2013 to 2019 and at Bedrocan Cannabis Corp.
from 2014 to 2015.
Dr. Mandelzys holds an MBA and doctorate from McGill University and an undergraduate degree from the University of Toronto.
Aktive Positionen von Allan Mandelzys
| Unternehmen | Position | Beginn |
|---|---|---|
8569975 Canada, Inc.
 8569975 Canada, Inc. Miscellaneous Commercial ServicesCommercial Services 8569975 Canada, Inc. provides other services. The private company is based in Dollard Des Ormeaux, Canada. | President | - |
Searchlight Pharma, Inc.
 Searchlight Pharma, Inc. Pharmaceuticals: MajorHealth Technology Searchlight Pharma, Inc. operates as a specialty healthcare company. It acquires and develops long life health care products. The company was founded in 2015 and is headquartered in Montreal, Canada. | Chairman | 01.04.2018 |
Ehemalige bekannte Positionen von Allan Mandelzys
| Unternehmen | Position | Ende |
|---|---|---|
| KANE BIOTECH INC. | Director/Board Member | 01.03.2023 |
| CLEMENTIA PHARMACEUTICALS INC | Director/Board Member | 01.01.2019 |
| BEDROCAN CANNABIS CORP | Director/Board Member | 01.09.2015 |
| THALLION PHARMACEUTICALS INC. | Chief Executive Officer | 01.07.2013 |
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | 01.12.2006 |
Ausbildung von Allan Mandelzys
| McGill University | Doctorate Degree |
| University of Toronto | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KANE BIOTECH INC. | Commercial Services |
| Private Unternehmen | 7 |
|---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
| Allelix Biopharmaceuticals, Inc. | Health Technology |
Thallion Pharmaceuticals, Inc.
 Thallion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thallion Pharmaceuticals, Inc. is a biotechnology company focused on developing new pharmaceutical products in the areas of infectious disease and oncology. Its products are Shigamabs, a dual antibody product for the treatment of Shigatoxin-producing E. coli bacterial infections and TLN-4601, a proprietary first in class small molecule with potential efficacy in multiple oncology indications. The company was founded in January 1998 and is headquartered in Dorval, Canada. | Health Technology |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada. | Health Technology |
Bedrocan Cannabis Corp.
 Bedrocan Cannabis Corp. Pharmaceuticals: OtherHealth Technology Bedrocan Cannabis Corp. produces, imports, and distributes pharmaceutical-grade medicinal cannabis to patients in Canada. Its products include Bedropuur, a tetrahydrocannibinol (THC) indica for THC extraction; Bedrocan, a sativa plant type cannabis; Bedica, an indica dominant strain of cannabis; and Bediol, Bedrolite, and Bedrobinol products, which are sativa dominant strains of cannabis. The company was founded by Murray Goldman and Marc Wayne on February 24, 2012 and is headquartered in Toronto, Canada. | Health Technology |
Searchlight Pharma, Inc.
Searchlight Pharma, Inc. Pharmaceuticals: MajorHealth Technology Searchlight Pharma, Inc. operates as a specialty healthcare company. It acquires and develops long life health care products. The company was founded in 2015 and is headquartered in Montreal, Canada. | Health Technology |
8569975 Canada, Inc.
8569975 Canada, Inc. Miscellaneous Commercial ServicesCommercial Services 8569975 Canada, Inc. provides other services. The private company is based in Dollard Des Ormeaux, Canada. | Commercial Services |
